Atlas Genetics Ltd-医療機器分野:企業M&A・提携分析

◆英語タイトル:Atlas Genetics Ltd - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8012953
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Atlas Genetics Ltd (Atlas Genetics) is an in vitro diagnostics company that offers decentralised, near-patient and point of care testing services. The company develops and offers diagnostic platforms such as io system and callisto system. Its io system is a diagnostic instrument and disposable cartridge system, which is designed for POC testing services to provide accurate solution to screening for the presence of STIs and HAIs. The company’s products and solutions are used in the diagnosis of sexually transmitted infections, neonatal sepsis, and hospital acquired infection. It serves clinicians and other healthcare professionals. The company opreates through its offices in the US and the UK. Atlas Genetics is headquartered in Trowbridge, the UK.

Atlas Genetics Ltd – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Atlas Genetics Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Atlas Genetics Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Atlas Genetics Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Atlas Genetics Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Atlas Genetics Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Atlas Genetics Ltd, Medical Equipment, Deal Details 10
Venture Financing 10
Atlas Genetics Raises USD35 Million in Series D Financing 10
Atlas Genetics Raises USD20 Million in Series C Financing 12
Atlas Genetics Raises US$27 Million In Series B Financing 14
Partnerships 16
Atlas Genetics Enters into Agreement with Pharma Company 16
Consort Medical Enters Into Co-Development Agreement With Atlas Genetics 17
Atlas Genetics Ltd – Key Competitors 18
Atlas Genetics Ltd – Key Employees 19
Atlas Genetics Ltd – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Corporate Communications 21
Oct 03, 2017: Atlas Genetics Appoints Life Sciences Veteran, Jeffrey Luber, as Chief Executive Officer; Founding CEO Dr John Clarkson Steps Up to Executive Chairman 21
Oct 03, 2017: Atlas Genetics Appoints Life Sciences Veteran, Jeffrey Luber, as Chief Executive Officer; Founding CEO Dr John Clarkson Steps Up to Executive Chairman 22
Product News 23
02/08/2016: Atlas Genetics Gains CE Approval for First Product 23
Product Approvals 24
Feb 08, 2016: Atlas Genetics Gains CE Approval for First Product 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Atlas Genetics Ltd, Medical Equipment, Key Facts 2
Atlas Genetics Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Atlas Genetics Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Atlas Genetics Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Atlas Genetics Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Atlas Genetics Ltd, Deals By Market, 2011 to YTD 2017 8
Atlas Genetics Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Atlas Genetics Raises USD35 Million in Series D Financing 10
Atlas Genetics Raises USD20 Million in Series C Financing 12
Atlas Genetics Raises US$27 Million In Series B Financing 14
Atlas Genetics Enters into Agreement with Pharma Company 16
Consort Medical Enters Into Co-Development Agreement With Atlas Genetics 17
Atlas Genetics Ltd, Key Competitors 18
Atlas Genetics Ltd, Key Employees 19
Atlas Genetics Ltd, Other Locations 20

★海外企業調査レポート[Atlas Genetics Ltd-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Technical University of Denmark:製薬・医療:M&Aディール及び事業提携情報
    Summary Technical University of Denmark (DTU) is an educational and research service provider. The university offers undergraduate programs, graduate programs, PhD programs, BSc programs, MSc programs, guest student services, accommodation services and others. It conducts research programs in the ar …
  • Avon Rubber Plc (AVON):企業の財務・戦略的SWOT分析
    Avon Rubber Plc (AVON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Chongqing Zhifei Biological Products Co Ltd (300122):製薬・医療:M&Aディール及び事業提携情報
    Summary Chongqing Zhifei Biological Products Co Ltd (Zhifei) is a vaccine manufacturer. The company offers HibACon, MeningACon, menwayc, mycobacterium vaccae, haemophilus influenzae type b conjugate vaccine and hepatitis A (live) vaccine, freeze-dried. It research, develops, produces and markets vac …
  • SSY Group Ltd (2005):企業の財務・戦略的SWOT分析
    Summary SSY Group Ltd (SSY), formerly Lijun International Pharmaceutical (Holding) Co Ltd is a pharmaceutical company that offers range of pharmaceutical products such as intravenous infusion solution. The company offers glass bottle infusion solutions, non-PVC soft bag infusions, and PP plastic bot …
  • Dermapharm AG-製薬・医療分野:企業M&A・提携分析
    Summary Dermapharm AG (Dermapharm) is a pharmaceutical company that offers dermatological and allergy medicines. The company provides products for allergies, disinfection and wound treatment, skin and hair care, corticoids, minerals, osteoporosis, fungal infections, vaginal thrush, other preparation …
  • Hong Kong Aircraft Engineering Co. Ltd:企業の戦略的SWOT分析
    Hong Kong Aircraft Engineering Co. Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Revalesio Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Revalesio Corp (Revalesio) is a developer of novel therapeutics for the treatment of inflammatory diseases. The company conducts research and development activities to develop therapeutics in the areas of respiratory, neuroscience and cardiovascular. Its product pipeline includes drugs targe …
  • iHeartMedia, Inc.:戦略・SWOT・企業財務分析
    iHeartMedia, Inc. - Strategy, SWOT and Corporate Finance Report Summary iHeartMedia, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Ricoh Imaging Co Ltd:企業の戦略的SWOT分析
    Ricoh Imaging Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • SRI International-医療機器分野:企業M&A・提携分析
    Summary SRI International (SRI) is a research institute which provides commercial research and development programs. It conducts research and development in the areas of biosciences, health and medical systems, chemistry and materials, communications and networks, computing, earth and space, economi …
  • Quarterhill Inc.:企業のM&A・事業提携・投資動向
    Quarterhill Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Quarterhill Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Croma-Pharma GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Croma-Pharma GmbH (Croma Pharma) is a pharmaceutical company which focuses on the development and commercialization of drugs in the field of aesthetic dermatology. It offers princess injectables, princess skincare, and princess lift products. The company’s princess skincare products comprise …
  • InspireMD Inc (NSPR):企業の財務・戦略的SWOT分析
    Summary InspireMD Inc (InspireMD) is a medical device company that develops and commercializes embolic prevention systems and neurovascular devices. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for us …
  • Sega Sammy Holdings Inc (6460):企業の財務・戦略的SWOT分析
    Sega Sammy Holdings Inc (6460) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • hVIVO Plc (HVO):企業の財務・戦略的SWOT分析
    Summary hVIVO Plc (hVIVO), formerly Retroscreen Virology Ltd is a biopharma company that develops human-based analytical platform to accelerate drug discovery and development. The company enables organisations to discover drugs and diagnostics and accelerate new product development. It uses human di …
  • Uber Technologies Inc:企業の戦略・SWOT・財務情報
    Uber Technologies Inc - Strategy, SWOT and Corporate Finance Report Summary Uber Technologies Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Mercer LLC:企業の戦略的SWOT分析
    Mercer LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • PT Dian Swastatika Sentosa Tbk (DSSA):企業の財務・戦略的SWOT分析
    PT Dian Swastatika Sentosa Tbk (DSSA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Spine Injury Solutions Inc (SPIN):企業の財務・戦略的SWOT分析
    Summary Spine Injury Solutions Inc (SPIN), formerly Spine Pain Management Inc is a medical service provider that provides medical technology and healthcare management solutions for liability spine injuries. The company provides services such as clinical management, and billing and collection of medi …
  • Airgas, Inc.:企業のM&A・事業提携・投資動向
    Airgas, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Airgas, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆